文献速递复苏、休克与脓毒症心脑血管急症

休克相关心脏骤停中的肺血管扩张剂治疗

Pulmonary Vasodilator Therapy in Shock-associated Cardiac Arrest.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01
一句话结论在LPS诱导休克相关心脏骤停的3月龄猪模型中,血流动力学导向心肺复苏(HD-CPR)加用吸入一氧化氮(iNO)提高45分钟存活率(10/10 vs 3/11,P=0.001)。

研究在3月龄猪(n=21)中静脉输注LPS诱导全身低血压后诱发心室颤动,随机分为HD-CPR加iNO组与不加iNO组;HD-CPR期间胸外按压深度按主动脉峰值压缩压100 mm Hg滴定,升压药按冠状动脉灌注压≥20 mm Hg滴定,复苏10分钟后开始除颤。主要终点45分钟存活率在iNO组更高(10/10 vs 3/11,P=0.001)。复苏期间iNO组肺动脉舒张压更低、冠状动脉灌注压与主动脉舒张压更高,且胸外按压更浅、前10分钟升压药次数更少。作者结论认为,在LPS诱导的休克相关心脏骤停中,HD-CPR加用iNO改善短期存活与复苏期间血流动力学。

要点

  • 3月龄猪LPS诱导休克相关室颤模型中,HD-CPR加iNO组45分钟存活10/10,不加iNO组3/11(P=0.001)。
  • 复苏期间iNO组冠状动脉灌注压21.1±1.5 vs 16.9±1.0 mm Hg(P=0.005),肺动脉舒张压10.9±2.4 vs 18.4±2.4 mm Hg(P=0.03)。
  • iNO组主动脉舒张压更高(36.6±1.6 vs 30.4±1.1 mm Hg,P<0.001),尽管胸外按压更浅(5.88±0.25 vs 6.46±0.40 cm,P=0.02)。
  • 前10分钟升压药次数iNO组更少(中位数4次[四分位距3-4]vs 5次[四分位距5-6],P=0.03)。
  • HD-CPR方案:按压深度按主动脉峰值压缩压100 mm Hg滴定,升压药按冠状动脉灌注压≥20 mm Hg滴定,复苏10分钟后开始除颤。

适用人群与场景

  • 3月龄猪(n=21),静脉输注LPS诱导全身低血压后诱发心室颤动的休克相关心脏骤停模型(动物实验,非人类临床人群)

诊断标准与关键阈值

  • HD-CPR期间胸外按压深度按主动脉峰值压缩压100 mm Hg滴定
  • 升压药给药按冠状动脉灌注压≥20 mm Hg滴定
  • 复苏10分钟后开始除颤尝试

处置流程与药物剂量

  • HD-CPR不加iNO为对照
  • 胸外按压深度按主动脉峰值压缩压100 mm Hg滴定
  • 升压药按冠状动脉灌注压≥20 mm Hg滴定给药
  • 复苏10分钟后开始除颤尝试

研究设计与关键结果

  • 动物实验:3月龄猪(n=21),LPS静脉输注诱导全身低血压后诱发心室颤动,随机分为HD-CPR加iNO组与HD-CPR不加iNO组,采用盲法治疗。
  • 主要终点45分钟存活率:iNO组10/10 vs 不加iNO组3/11(P=0.001)。
  • 复苏期间肺动脉舒张压:iNO组10.9±2.4 vs 不加iNO组18.4±2.4 mm Hg(P=0.03)。
  • 复苏期间冠状动脉灌注压:iNO组21.1±1.5 vs 不加iNO组16.9±1.0 mm Hg(P=0.005)。
  • 复苏期间主动脉舒张压:iNO组36.6±1.6 vs 不加iNO组30.4±1.1 mm Hg(P<0.001)。
  • 胸外按压深度:iNO组5.88±0.25 vs 不加iNO组6.46±0.40 cm(P=0.02)。
  • 前10分钟升压药次数:iNO组中位数4次(四分位距3-4)vs 不加iNO组5次(四分位距5-6)(P=0.03)。

证据类型、等级与局限

  • 证据类型:动物实验(3月龄猪模型),随机、盲法分组
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者结论认为,在LPS诱导的休克相关心脏骤停中,HD-CPR加用iNO改善短期存活与复苏期间血流动力学;该结论来自猪模型,原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Many in-hospital cardiac arrests are precipitated by hypotension, often associated with systemic inflammation. These patients are less likely to be successfully resuscitated, and novel approaches to their treatment are needed.

OBJECTIVES: To determine if the addition of inhaled nitric oxide (iNO) to hemodynamic-directed cardiopulmonary resuscitation (HD-CPR) would improve short-term survival from cardiac arrest associated with shock and systemic inflammation.

METHODS: In 3-month-old swine (n = 21), LPS was intravenously infused, inducing systemic hypotension. Ventricular fibrillation was induced, and animals were randomized to blinded treatment with either: 1) HD-CPR with iNO, or 2) HD-CPR without iNO. During HD-CPR, chest compression depth was titrated to peak aortic compression pressure of 100 mm Hg, and vasopressor administration was titrated to coronary perfusion pressure greater than or equal to 20 mm Hg. Defibrillation attempts began after 10 minutes of resuscitation. The primary outcome was 45-minute survival.

MEASUREMENTS AND MAIN RESULTS: The iNO group had higher rates of 45-minute survival (10 of 10 vs. 3 of 11; P = 0.001). During cardiopulmonary resuscitation, the iNO group had lower pulmonary artery relaxation pressure (mean ± SEM, 10.9 ± 2.4 vs. 18.4 ± 2.4 mm Hg; P = 0.03), higher coronary perfusion pressure (21.1 ± 1.5 vs. 16.9 ± 1.0 mm Hg; P = 0.005), and higher aortic relaxation pressure (36.6 ± 1.6 vs. 30.4 ± 1.1 mm Hg; P < 0.001) despite shallower chest compressions (5.88 ± 0.25 vs. 6.46 ± 0.40 cm; P = 0.02) and fewer vasopressor doses in the first 10 minutes (median, 4 [interquartile range, 3-4] vs. 5 [interquartile range, 5-6], P = 0.03).

CONCLUSIONS: The addition of iNO to HD-CPR in LPS-induced shock-associated cardiac arrest improved short-term survival and intraarrest hemodynamics.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Morgan RW, Sutton RM, Karlsson M, et al. Pulmonary Vasodilator Therapy in Shock-associated Cardiac Arrest. Am J Respir Crit Care Med. 2018. PMID: 29244522. doi:10.1164/rccm.201709-1818OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。